Hunan Xianshi Pharmaceutical

Hunan Xianshi Pharmaceutical Co., Ltd. is a China-based pharmaceutical company founded in 2021, specializing in the development and manufacturing of high-quality APIs and finished dosage forms. Headquartered in the Liuyang Economic and Technological Development Zone, the company operates as a key production and R&D hub for the Yunnan Sincere Pharmaceutical Group. Its portfolio emphasizes complex formulations and high-barrier generics, particularly in the fields of respiratory inhalation, cardiovascular health, and metabolic diseases. With a robust pipeline of over 50 projects, including bioequivalence studies for inhaled corticosteroids and combination lipid-lowering therapies, the company is positioning itself as a significant player in the domestic Chinese pharmaceutical market. Hunan Xianshi is recognized as a National High-Tech Enterprise and maintains advanced manufacturing facilities for oral solids, injections, and specialized inhalation solutions.